PHARMACO-NET Trademark

Trademark Overview

On Tuesday, October 25, 2022, a trademark application was filed for PHARMACO-NET with the United States Patent and Trademark Office. The USPTO has given the PHARMACO-NET trademark a serial number of 97646979. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Saturday, September 13, 2025. This trademark is owned by Calici Co., Ltd.. The PHARMACO-NET trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Advisory services related to the research and development of pharmaceuticals; consultancy in the field of research and development of pharmaceutical and medical products; advisory services in the field of research and development of pharmaceutical products; consultancy and information services provided via the internet relating to research and development of pharmaceutical products; consultancy and information services relating to research and development of pharmaceutical products; consultancy and information services relating to biopharmaceutical products; information services relating to research and development of medical products
pharmaco-net

General Information

Serial Number97646979
Word MarkPHARMACO-NET
Filing DateTuesday, October 25, 2022
Status641 - NON-FINAL ACTION - MAILED
Status DateSaturday, September 13, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, January 9, 2024

Trademark Statements

Description of MarkThe mark consists of the stylized word "PHARMACO-NET" with a large capital "P". To the left of the word is a circuit pattern.
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesAdvisory services related to the research and development of pharmaceuticals; consultancy in the field of research and development of pharmaceutical and medical products; advisory services in the field of research and development of pharmaceutical products; consultancy and information services provided via the internet relating to research and development of pharmaceutical products; consultancy and information services relating to research and development of pharmaceutical products; consultancy and information services relating to biopharmaceutical products; information services relating to research and development of medical products

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, November 3, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCalici Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDaejeon -
KR
Party NameCalici Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDaejeon -
KR

Trademark Events

Event DateEvent Description
Tuesday, August 8, 2023ASSIGNED TO EXAMINER
Friday, October 28, 2022NEW APPLICATION ENTERED
Tuesday, November 8, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, November 9, 2022NOTICE OF DESIGN SEARCH CODE E-MAILED
Saturday, August 12, 2023NON-FINAL ACTION WRITTEN
Saturday, August 12, 2023NON-FINAL ACTION E-MAILED
Saturday, August 12, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, November 3, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, November 3, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, November 3, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, January 9, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Monday, November 6, 2023ASSIGNED TO EXAMINER
Tuesday, December 5, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 20, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 9, 2024PUBLISHED FOR OPPOSITION
Tuesday, March 5, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, September 4, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 4, 2024SOU EXTENSION 1 GRANTED
Wednesday, March 5, 2025SOU EXTENSION 2 FILED
Tuesday, April 30, 2024TEAS POST PUBLICATION AMENDMENT RECEIVED
Wednesday, September 4, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, September 4, 2024SOU EXTENSION 1 FILED
Wednesday, March 5, 2025SOU TEAS EXTENSION RECEIVED
Wednesday, March 5, 2025SOU EXTENSION 2 GRANTED
Monday, May 12, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, March 6, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 12, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, May 12, 2025TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Monday, May 12, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, May 12, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, May 12, 2025TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Monday, May 12, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, June 9, 2025TEAS PETITION TO AMEND BASIS RECEIVED
Monday, July 28, 2025ASSIGNED TO PETITION STAFF
Monday, July 28, 2025PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Monday, July 28, 2025JURISDICTION RESTORED TO EXAMINING ATTORNEY
Monday, August 11, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, September 13, 2025PREVIOUS ALLOWANCE COUNT WITHDRAWN
Saturday, September 13, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, September 13, 2025NON-FINAL ACTION E-MAILED
Saturday, September 13, 2025NON-FINAL ACTION WRITTEN
Wednesday, September 3, 2025CASE RETURNED TO EXAMINATION
Monday, August 11, 2025NON-FINAL ACTION E-MAILED
Monday, August 11, 2025SU - NON-FINAL ACTION - WRITTEN
Wednesday, September 3, 2025NOTICE OF ALLOWANCE CANCELLED

Related Keywords

pharmaco products research development services pharmaceutical consultancy information relating medical field